Tryp Therapeutics Stock Z Score
TRYPFDelisted Stock | USD 0.05 0 6.89% |
Tryp |
Tryp Therapeutics OTC Stock Z Score Analysis
Tryp Therapeutics' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Tryp Therapeutics Z Score | -9.9 |
Most of Tryp Therapeutics' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tryp Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, Tryp Therapeutics has a Z Score of -9.9. This is 246.67% lower than that of the Healthcare sector and notably lower than that of the Biotechnology industry. The z score for all United States stocks is notably higher than that of the company.
Tryp Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tryp Therapeutics' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Tryp Therapeutics could also be used in its relative valuation, which is a method of valuing Tryp Therapeutics by comparing valuation metrics of similar companies.Tryp Therapeutics is currently under evaluation in z score category among its peers.
Tryp Fundamentals
Return On Equity | -9.22 | |||
Return On Asset | -2.05 | |||
Current Valuation | 4.17 M | |||
Shares Outstanding | 96.42 M | |||
Shares Owned By Insiders | 47.24 % | |||
Shares Owned By Institutions | 0.04 % | |||
Price To Book | 2.50 X | |||
EBITDA | (7.36 M) | |||
Net Income | (7.49 M) | |||
Cash And Equivalents | 2.85 M | |||
Cash Per Share | 0.03 X | |||
Current Ratio | 6.14 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (5.81 M) | |||
Earnings Per Share | (0.13) X | |||
Beta | -1.29 | |||
Market Capitalization | 6.56 M | |||
Total Asset | 2.34 M | |||
Z Score | -9.9 | |||
Net Asset | 2.34 M |
About Tryp Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tryp Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tryp Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tryp Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Tryp OTC Stock
If you are still planning to invest in Tryp Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tryp Therapeutics' history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |